Home ›
Entities
› academia
› A retrospective analysis of practical benefits and caveats of the new <scp>WHO</scp> 2021 central nervous system tumor classification scheme in low‐resource settings: “A perspective from low‐ and middle‐income countries”
A retrospective analysis of practical benefits and caveats of the new <scp>WHO</scp> 2021 central nervous system tumor classification scheme in low‐resource settings: “A perspective from low‐ and middle‐income countries”
Research article (Neuropathology, 2023) · cited 10× · AI/ML
A retrospective analysis of practical benefits and caveats of the new WHO 2021 central nervous system tumor classification scheme in low‐resource settings: “A perspective from low‐ and middle‐income countries”
Summary
A retrospective analysis of practical benefits and caveats of the new WHO 2021 central nervous system tumor classification scheme in low‐resource settings: “A perspective from low‐ and middle‐income countries” is a scholarly article[1].
Key Facts
A retrospective analysis of practical benefits and caveats of the new WHO 2021 central nervous system tumor classification scheme in low‐resource settings: “A perspective from low‐ and middle‐income countries”'s instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). A retrospective analysis of practical benefits and caveats of the new <scp>WHO</scp> 2021 central nervous system tumor classification scheme in low‐resource settings: “A perspective from low‐ and middle‐income countries”. Retrieved May 24, 2026, from https://4ort.xyz/entity/a-retrospective-analysis-of-practical-benefits-and-caveats-of-the-new-scp-who-scp-2021-central-nervous-system-tumor-clas
MLA“A retrospective analysis of practical benefits and caveats of the new <scp>WHO</scp> 2021 central nervous system tumor classification scheme in low‐resource settings: “A perspective from low‐ and middle‐income countries”.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/a-retrospective-analysis-of-practical-benefits-and-caveats-of-the-new-scp-who-scp-2021-central-nervous-system-tumor-clas.
BibTeX@misc{4ortxyz_a-retrospective-analysis-of-practical-benefits-and-caveats-of-the-new-scp-who-scp-2021-central-nervous-system-tumor-clas_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{A retrospective analysis of practical benefits and caveats of the new <scp>WHO</scp> 2021 central nervous system tumor classification scheme in low‐resource settings: “A perspective from low‐ and middle‐income countries”}}, year = {2026}, url = {https://4ort.xyz/entity/a-retrospective-analysis-of-practical-benefits-and-caveats-of-the-new-scp-who-scp-2021-central-nervous-system-tumor-clas}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): A retrospective analysis of practical benefits and caveats of the new <scp>WHO</scp> 2021 central nervous system tumor classification scheme in low‐resource settings: “A perspective from low‐ and middle‐income countries” — https://4ort.xyz/entity/a-retrospective-analysis-of-practical-benefits-and-caveats-of-the-new-scp-who-scp-2021-central-nervous-system-tumor-clas (retrieved 2026-05-24)
